• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺密度、MRI 背景实质增强与乳腺癌风险。

Mammographic density, MRI background parenchymal enhancement and breast cancer risk.

机构信息

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

出版信息

Ann Oncol. 2013 Nov;24 Suppl 8(Suppl 8):viii37-viii41. doi: 10.1093/annonc/mdt310.

DOI:10.1093/annonc/mdt310
PMID:24131968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3894109/
Abstract

Mammographic density (MD), representing connective and epithelial tissue (fibroglandular tissue, FGT) is a major risk factor for breast cancer. In an analysis of an autopsy series (Bartow SA, Pathak DR, Mettler FA. Radiographic microcalcification and parenchymal patterns as indicators of histologic "high-risk" benign breast disease. Cancer 1990; 66: 1721-1725, Bartow SA, Pathak DR, Mettler FA et al. Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am J Epidemiol 1995; 142: 813-819), MD was found to be strongly correlated with the collagen and epithelial content of the breast (Li T, Sun L, Miller N et al. The association of measured breast tissue characteristics with MD and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 343-349), and another report showed that breast epithelium was highly concentrated in the areas of collagen concentration (Hawes D, Downey S, Pearce CL et al. Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res 2006; 8: R24). Collagen comprises the overwhelming majority of the FGT, occupying an area on the slides obtained from the autopsy series some 15 times the area of glandular tissue. The relationship of MD with breast cancer risk appears likely to be due to a major extent to increasing epithelial cell numbers with increasing MD. FGT is also seen in breast magnetic resonance imaging (breast MRI) and, as expected, it has been shown that this measure of FGT (MRI-FGT) is highly correlated with MD. A contrast-enhanced breast MRI shows that normal FGT 'enhances' (background parenchymal enhancement, BPE) after contrast agent is administered(Morris EA. Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 2007; 45: 863-880, vii., Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007; 244: 356-378), and a recent study suggests that BPE is also a major breast cancer risk factor, possibly as important as, and independent of MD (King V, Brooks JD, Bernstein JL et al. BPE at breast MR imaging and breast cancer risk. Radiology 2011; 260: 50-60). BPE is much more sensitive to the effects of menopause and tamoxifen than is FGT (King V, Gu Y, Kaplan JB et al. Impact of menopausal status on BPE and fibroglandular tissue on breast MRI. Eur Radiol 2012; 22: 2641-2647, King V, Kaplan J, Pike MC et al. Impact of tamoxifen on amount of fibroglandular tissue, BPE, and cysts on breast MRI. Breast J 2012; 18: 527-534). Changes in MD and BPE may be most useful in predicting response to chemopreventive agents aimed at blocking breast cell proliferation. More study of the biological basis of the effects of MD and BPE is needed if we are to fully exploit these factors in developing chemopreventive approaches to breast cancer.

摘要

乳腺密度(MD)代表着结缔组织和上皮组织(纤维腺体组织,FGT),是乳腺癌的主要危险因素。在对一系列尸检的分析中(Bartow SA、Pathak DR、Mettler FA。放射微钙化和实质模式作为组织学“高危”良性乳腺疾病的指标。癌症 1990;66:1721-1725,Bartow SA、Pathak DR、Mettler FA 等。乳腺 X 线摄影模式:混杂因素和乳腺癌危险因素的串联。美国流行病学杂志 1995;142:813-819),发现 MD 与乳腺的胶原蛋白和上皮含量密切相关(Li T、Sun L、Miller N 等。测量的乳腺组织特征与 MD 和乳腺癌其他危险因素的关系。癌症流行病学生物标志物预防 2005;14:343-349),另一项研究表明乳腺上皮组织高度集中在胶原蛋白浓度高的区域(Hawes D、Downey S、Pearce CL 等。致密乳腺基质组织显示乳腺上皮细胞高度浓缩,但增殖活性没有增加。乳腺癌研究 2006;8:R24)。胶原蛋白构成了 FGT 的绝大多数,在尸检系列中获得的幻灯片上占据了大约是腺体组织面积 15 倍的区域。MD 与乳腺癌风险的关系似乎主要归因于随着 MD 的增加,上皮细胞数量的增加。FGT 也可见于乳腺磁共振成像(乳腺 MRI)中,正如预期的那样,已经表明这种 FGT 测量方法(MRI-FGT)与 MD 高度相关。增强后的乳腺 MRI 显示正常的 FGT 在给予造影剂后会“增强”(背景实质增强,BPE)(Morris EA。诊断性乳腺磁共振成像:现状和未来方向。放射学临床北美 2007;45:863-880,vii.,Kuhl C. 乳腺 MRI 的现状。第一部分。技术选择、图像解释、诊断准确性以及向临床实践的转移。放射学 2007;44:356-378),最近的一项研究表明 BPE 也是乳腺癌的一个主要危险因素,可能与 MD 一样重要,并且独立于 MD(King V、Brooks JD、Bernstein JL 等。乳腺 MRI 上的 BPE 和乳腺癌风险。放射学 2011;260:50-60)。BPE 对绝经和他莫昔芬的影响比 FGT 敏感得多(King V、Gu Y、Kaplan JB 等。绝经状态对乳腺 MRI 上的 BPE 和纤维腺体组织的影响。欧洲放射学 2012;22:2641-2647,King V、Kaplan J、Pike MC 等。他莫昔芬对乳腺 MRI 上的纤维腺体组织、BPE 和囊肿的影响。乳房 J 2012;18:527-534)。MD 和 BPE 的变化可能最有助于预测针对阻止乳腺细胞增殖的化学预防剂的反应。如果我们要充分利用 MD 和 BPE 这些因素来开发乳腺癌的化学预防方法,就需要对其作用的生物学基础进行更多的研究。

相似文献

1
Mammographic density, MRI background parenchymal enhancement and breast cancer risk.乳腺密度、MRI 背景实质增强与乳腺癌风险。
Ann Oncol. 2013 Nov;24 Suppl 8(Suppl 8):viii37-viii41. doi: 10.1093/annonc/mdt310.
2
Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.乳腺 MRI 背景实质强化(BPE)的组织病理学特征。
Breast Cancer Res Treat. 2018 Nov;172(2):487-496. doi: 10.1007/s10549-018-4916-6. Epub 2018 Aug 23.
3
Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?磁共振成像中背景实质强化、纤维腺体量的定性评估以及乳腺X线密度与乳腺癌风险相关吗?
Radiology. 2015 Aug;276(2):371-80. doi: 10.1148/radiol.2015142304. Epub 2015 May 12.
4
MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival.辅助内分泌激素治疗浸润性小叶乳腺癌患者的 MRI 背景实质强化、纤维腺体组织和乳腺 X 线摄影密度与生存的关系。
Breast Cancer Res. 2020 Aug 20;22(1):93. doi: 10.1186/s13058-020-01329-z.
5
Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.绝经状态对乳腺 MRI 背景实质强化和纤维腺体组织的影响。
Eur Radiol. 2012 Dec;22(12):2641-7. doi: 10.1007/s00330-012-2553-8. Epub 2012 Jul 4.
6
Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.乳腺磁共振筛查项目中纤维-腺体组织(FGT)和背景实质强化(BPE)与乳腺癌风险和假阳性的关系:一项回顾性队列研究。
Eur Radiol. 2019 Sep;29(9):4678-4690. doi: 10.1007/s00330-019-06020-2. Epub 2019 Feb 22.
7
The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue.双侧输卵管卵巢切除术对乳腺 MRI 背景实质增强和纤维腺体组织的影响。
Eur Radiol. 2014 Jan;24(1):162-8. doi: 10.1007/s00330-013-2993-9. Epub 2013 Aug 28.
8
The relationship of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancer.高危女性和乳腺癌女性乳腺钼靶摄影与磁共振成像中乳腺密度的关系。
Clin Imaging. 2015 Nov-Dec;39(6):987-92. doi: 10.1016/j.clinimag.2015.08.001. Epub 2015 Aug 6.
9
Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging.他莫昔芬对乳腺磁共振成像中纤维腺体组织、背景实质强化和囊肿数量的影响。
Breast J. 2012 Nov-Dec;18(6):527-34. doi: 10.1111/tbj.12002. Epub 2012 Sep 25.
10
Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.18F-FDG PET/CT对乳腺实质摄取的定量评估:与年龄、背景实质强化及MRI上纤维腺体量的相关性
J Nucl Med. 2016 Oct;57(10):1518-1522. doi: 10.2967/jnumed.116.174904. Epub 2016 May 26.

引用本文的文献

1
Early thelarche, reproductive hormones, and MRI-based breast density: a prospective study in China.性早熟、生殖激素与基于磁共振成像的乳腺密度:一项中国的前瞻性研究。
Breast Cancer Res. 2025 Sep 1;27(1):158. doi: 10.1186/s13058-025-02116-4.
2
Urinary Levels of Endocrine-Disrupting Chemicals and Breast Density in Young Women.年轻女性尿液中内分泌干扰化学物质水平与乳腺密度
Cancer Epidemiol Biomarkers Prev. 2025 Aug 1;34(8):1306-1313. doi: 10.1158/1055-9965.EPI-24-1694.
3
Influence of Breast Density and Menopausal Status on Background Parenchymal Enhancement in Contrast-Enhanced Mammography: Insights from a Retrospective Analysis.乳腺密度和绝经状态对对比增强乳腺摄影中背景实质强化的影响:一项回顾性分析的见解
Cancers (Basel). 2024 Dec 24;17(1):11. doi: 10.3390/cancers17010011.
4
Early Detection of Breast Cancer in MRI Using AI.利用人工智能在磁共振成像中早期检测乳腺癌
Acad Radiol. 2025 Mar;32(3):1218-1225. doi: 10.1016/j.acra.2024.10.014. Epub 2024 Oct 30.
5
Qualitative assessments of density and background parenchymal enhancement on contrast-enhanced spectral mammography associated with breast cancer risk in high-risk women.在高危女性中,对比增强光谱乳腺摄影术与乳腺癌风险相关的密度和背景实质增强的定性评估。
Br J Radiol. 2023 Aug;96(1148):20220051. doi: 10.1259/bjr.20220051. Epub 2023 May 25.
6
Obesity and metabolic dysfunction correlate with background parenchymal enhancement in premenopausal women.肥胖和代谢功能障碍与绝经前妇女的背景实质增强相关。
Obesity (Silver Spring). 2023 Feb;31(2):479-486. doi: 10.1002/oby.23649. Epub 2023 Jan 11.
7
The Mammary Tumor Microenvironment.乳腺肿瘤微环境。
Adv Exp Med Biol. 2020;1296:163-181. doi: 10.1007/978-3-030-59038-3_10.
8
Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI.乳腺癌新辅助治疗的反应预测性:动态对比增强磁共振成像中背景实质强化的定性分析
J Pers Med. 2021 Apr 1;11(4):256. doi: 10.3390/jpm11040256.
9
Effect of Vitamin D Supplementation on Risk of Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.补充维生素D对乳腺癌风险的影响:一项随机对照试验的系统评价和荟萃分析
Front Nutr. 2021 Apr 1;8:655727. doi: 10.3389/fnut.2021.655727. eCollection 2021.
10
Multiparametric F-FDG PET/MRI of the Breast: Are There Differences in Imaging Biomarkers of Contralateral Healthy Tissue Between Patients With and Without Breast Cancer?多参数 F-FDG PET/MRI 乳腺成像:乳腺癌患者与非乳腺癌患者对侧健康组织的影像学生物标志物是否存在差异?
J Nucl Med. 2020 Jan;61(1):20-25. doi: 10.2967/jnumed.119.230003. Epub 2019 Jun 28.

本文引用的文献

1
Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging.他莫昔芬对乳腺磁共振成像中纤维腺体组织、背景实质强化和囊肿数量的影响。
Breast J. 2012 Nov-Dec;18(6):527-34. doi: 10.1111/tbj.12002. Epub 2012 Sep 25.
2
Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.芳香酶抑制剂对乳腺磁共振成像中背景实质强化和纤维腺体组织量的影响。
Radiology. 2012 Sep;264(3):670-8. doi: 10.1148/radiol.12112669. Epub 2012 Jul 6.
3
Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.绝经状态对乳腺 MRI 背景实质强化和纤维腺体组织的影响。
Eur Radiol. 2012 Dec;22(12):2641-7. doi: 10.1007/s00330-012-2553-8. Epub 2012 Jul 4.
4
Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation.由于控制性卵巢过度刺激,短期高水平内源性雌激素会显著增加乳腺上皮细胞增殖。
Breast Cancer Res Treat. 2012 Apr;132(2):653-60. doi: 10.1007/s10549-011-1870-y. Epub 2011 Nov 15.
5
Breast density influences tumor subtypes and tumor aggressiveness.乳腺密度会影响肿瘤亚型和肿瘤侵袭性。
J Natl Cancer Inst. 2011 Aug 3;103(15):1143-5. doi: 10.1093/jnci/djr263. Epub 2011 Jul 27.
6
Background parenchymal enhancement at breast MR imaging and breast cancer risk.背景实质增强在乳腺磁共振成像和乳腺癌风险中的作用。
Radiology. 2011 Jul;260(1):50-60. doi: 10.1148/radiol.11102156. Epub 2011 Apr 14.
7
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.他莫昔芬诱导的乳腺密度降低与乳腺癌风险降低:一项巢式病例对照研究。
J Natl Cancer Inst. 2011 May 4;103(9):744-52. doi: 10.1093/jnci/djr079. Epub 2011 Apr 11.
8
Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.生殖史与三种生物标志物定义的三种乳腺癌亚型风险的关系。
Cancer Causes Control. 2011 Mar;22(3):399-405. doi: 10.1007/s10552-010-9709-0. Epub 2010 Dec 24.
9
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.局部切除原位导管癌女性中他莫昔芬和放疗的效果:来自英国/澳新 DCIS 试验的长期结果。
Lancet Oncol. 2011 Jan;12(1):21-9. doi: 10.1016/S1470-2045(10)70266-7. Epub 2010 Dec 7.
10
Using mammographic density to predict breast cancer risk: dense area or percentage dense area.使用乳腺密度预测乳腺癌风险:致密区域或致密百分比区域。
Breast Cancer Res. 2010;12(6):R97. doi: 10.1186/bcr2778. Epub 2010 Nov 18.